Amvissa Pharmaceuticals

Delhi, India Founded: 2012 • Age: 14 yrs
Produces high-quality finished pharmaceutical formulations.
Annual revenue $7,861 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Amvissa Pharmaceuticals

Amvissa Pharmaceuticals is a company based in Delhi (India) founded in 2012. It operates as a B2B. Amvissa Pharmaceuticals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

  • Headquarter Delhi, India
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Amvissa Pharmaceuticals Private Limited
  • Date of Incorporation 04 Jan, 2012
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $7.86 K (USD)
    0
    as on Mar 31, 2017
  • Net Profit
    -$2.68 K (USD)
    0
    as on Mar 31, 2017
  • EBITDA
    -$2.52 K (USD)
    0
    as on Mar 31, 2017
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Amvissa Pharmaceuticals

Premium access

Detailed funding history for Amvissa Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Amvissa Pharmaceuticals

Investments
Premium access

Investment portfolio details for Amvissa Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Amvissa Pharmaceuticals

Premium access

Detailed financials for Amvissa Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Amvissa Pharmaceuticals Comparisons

Amvissa Pharmaceuticals Primary company
Description
Produces high-quality finished pharmaceutical formulations.
Location
Delhi, India
Founded Year
2012
Annual Revenue
$7.86 K (USD)
Net Profit
-$2.68 K (USD)
EBITDA
-$2.52 K (USD)
Employees
Not available
Premium access

Peer comparison for Amvissa Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Amvissa Pharmaceuticals

Amvissa Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Contract development and manufacturing organization for proprietary and generic drugs
Locked Locked Locked
CDMO focusing on spectrum of dosage forms and therapeutic segments
Locked Locked Locked
Company offering a suite of R&D and manufacturing services for small molecules and generics
Locked Locked Locked
Pharmaceutical development and manufacturing services are offered contractually.
Locked Locked Locked
CDMO with a focus on early phase drug product development
Locked Locked Locked
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed competitors of Amvissa Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Amvissa Pharmaceuticals

Premium access

Complete news archive for Amvissa Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amvissa Pharmaceuticals

Amvissa Pharmaceuticals was founded in 2012.

Amvissa Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Annual revenue of Amvissa Pharmaceuticals is $7.86K as on Mar 31, 2017.

Amvissa Pharmaceuticals produces high-quality finished pharmaceutical formulations through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and finished formulations. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Amvissa Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available